21 C
Agartala
Wednesday, February 28, 2024

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

 Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Share post:

Subscribe

Adspot_imgspot_img

Popular

More like this
Related

ASHA workers demand better pay and benefits, submits memorandum to CMO of West district

BY TC News Desk Agartala, 28th February 2024 :   A...

All Tripura Blind Association submits memorandum to Director of ICA department

BY TC News Desk Agartala, 28th February 2024 :   The...

Residents of Madhupur express outrage over poor quality road work despite MLA’s assurances

BY TC News Desk Agartala, 28th February 2024 :   Despite...

One held with cannabis worth Rs 1.5 crores in Jatrapur

BY TC News Desk Agartala, 28th February 2024 : In...